Clinical signs and mortality of ICR mice after a single oral administration of varying doses of the PAT protein
| Sex | Group (Dose: mg/kg) | Sample size | Clinical signs | Mortality (%) |
|---|---|---|---|---|
| Male | G1 (0) | 5 | - | 0 |
| G2 (1000) | 5 | - | 0 | |
| G3 (2000) | 5 | - | 0 | |
| G4 (4000) | 5 | - | 0 | |
| Female | G1 (0) | 5 | - | 0 |
| G2 (1000) | 5 | - | 0 | |
| G3 (2000) | 5 | - | 0 | |
| G4 (4000) | 5 | - | 0 |
-, No abnormal findings
